Endava plc SEC Filing
Endava (DAVA) shareholder filed a Form 144 to sell up to 7,494 common shares with an aggregate market value of $52,917, on or about November 13, 2025, on the NYSE through Stifel Nicolaus & Company Inc. The filing lists 56,208,871 shares outstanding as context.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Endava (DAVA) shareholder filed a Form 144 to sell up to 7,494 common shares with an aggregate market value of $52,917, on or about November 13, 2025, on the NYSE through Stifel Nicolaus & Company Inc.
The filing lists 56,208,871 shares outstanding as context. The shares to be sold were acquired via restricted stock units on May 28, 2025 (amount acquired: 7,396 shares). In the prior three months, Alastair Lukies reported a sale of 3,504 shares on October 31, 2025 for $32,335.
Insights
Routine Form 144 notice for a planned small share sale.
This filing is a notice of a proposed sale of restricted or control securities under Rule 144. It lists a plan to sell up to 7,494 shares of Endava common stock with an $52,917 aggregate market value, using the NYSE and broker Stifel. Such notices are administrative and do not alter company operations.
The shares were originally acquired via restricted stock units on May 28, 2025. The document also notes a prior sale by Alastair Lukies of 3,504 shares on October 31, 2025 for $32,335. Actual sale activity depends on market conditions and holder decisions.
For context, shares outstanding were 56,208,871. This is a baseline figure. Subsequent filings may provide execution details if sales occur.
AI-generated analysis. How Rhea-AI works. Not financial advice.